Regular ArticleGene Structure and Upstream Regulatory Regions of Human CYP2C9 and CYP2C18
References (0)
Cited by (73)
Pharmacogenomics
2018, Emery and Rimoin's Principles and Practice of Medical Genetics and Genomics: FoundationsPharmacogenetics and Pharmacogenomics
2013, Emery and Rimoin's Principles and Practice of Medical GeneticsEpoxyeicosatrienoic acids, cell signaling and angiogenesis
2007, Prostaglandins and Other Lipid MediatorsFrom endothelium-derived hyperpolarizing factor (EDHF) to angiogenesis: Epoxyeicosatrienoic acids (EETs) and cell signaling
2006, Pharmacology and TherapeuticsEvaluation of viral and mammalian promoters for driving transgene expression in mouse liver
2006, Biochemical and Biophysical Research CommunicationsCitation Excerpt :Plasmid construction. All CYP promoter sequences were selected based on previously published gene sequences [6–10] and synthesized by PCR with a KpnI site attached to the 5′ end of the forward and an MluI site to the 5′ end of the reverse primer using human genomic DNA sequences as the template. PCR kits were purchased from Gene Choice (Frederick, MD).
Advances in pharmacogenomics and individualized drug therapy: Exciting challenges that lie ahead
2004, European Journal of Pharmacology
Copyright © 1993 Academic Press. All rights reserved.